Accessibility: Skip TopNav
Figure 2: Percentage of Patients With 35% and 50% Reduction in FIAS and TCS
Percentage of Patients With 35% and 50% Reduction in FIAS and TCS by Time Point, Patients With FIAS and/or TCS at Baseline
Format
PNG
Quelle:
Zynerba Pharmaceuticals, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein